Login to Your Account

Amgen Suing Roche For Infringing On EPO Patents

By Karen Pihl-Carey

Thursday, November 10, 2005
Taking a pre-emptive strike to protect its anemia drug Epogen, Amgen Inc. filed a lawsuit against F. Hoffmann-La Roche Ltd. and its subsidiaries to prevent the pharmaceutical company from selling a pegylated version of recombinant human erythropoietin. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription